New Vaccine Coming to Omicron Variant

Pfizer CEO Bourla talked about the new vaccine developed for the Omicron variant in his statements before a health conference broadcast on CNBC. Speaking as “I don’t know yet if the fourth dose is necessary, it needs to be tested”, the CEO also announced when the vaccine will come to us.

Stating that the new vaccine will arrive in March, Burla’s statements on the subject coincided with a period when some countries were considering the second booster vaccine due to the Omicron variant. As you know, Israel was the first country to approve the 4th vaccine due to the Omicron variant. In addition, after this new and contagious variant, restrictions have returned in many countries.

The CEO of Moderna said that the 4th vaccine may still be needed.

Stephen Bancel, CEO of Moderna, stated in a statement that the current booster vaccines will decrease and become insufficient in the last quarter of 2022. For this reason, the CEO of Moderna, announcing that the 4th dose is necessary, has previously said that they have developed a reminder vaccine for Omicron.

Pfizer CEO Burla announced three new agreements, stating that Pfizer will use mRNA technology in new Covid-19 vaccines. One of Pfizer’s deals is a $1.35 billion deal and includes therapies that involve genetic engineering.

As a result, as far as we understand, Pfizer CEO Burla predicts that with the new Omicron variant vaccine they have developed, a 4th dose may not be needed and they will be able to solve this problem completely. The CEO of Moderna, on the other hand, thinks that the 4th vaccine is still needed and that reminder doses should be given until it is developed.